Tag: PFE

Finance

Trader’s Recap : Pfizer (NYSE:PFE), ChinaCache (NASDAQ:CCIH), Lennox International (NYSE:LII), SunTrust Banks, Inc. (NYSE:STI), QTS Realty Trust, Inc. (NYSE:QTS)

Zacks reaffirmed their neutral rating on shares of Pfizer (NYSE:PFE) in a report released on Friday. Zacks currently has a $30.00 price objective on the stock. Pfizer Inc. (NYSE:PFE) belongs to Healthcare sector. Its net profit margin is 59.30% and weekly performance is 0.93%. On last trading day company shares ended up $29.21. Pfizer Inc. (NYSE:PFE) distance from 50-day simple moving average (SMA50) is -0.48%. Shares of Lennox International (NYSE:LII) have … Continue reading Trader’s Recap : Pfizer (NYSE:PFE), ChinaCache (NASDAQ:CCIH), Lennox International (NYSE:LII), SunTrust Banks, Inc. (NYSE:STI), QTS Realty Trust, Inc. (NYSE:QTS)

John Bellich
Finance

Trader’s Recap : Pfizer (NYSE:PFE), SandRidge Energy (NYSE:SD), Pennsylvania Real Estate Investment Trust (NYSE:PEI), Tower Semiconductor Ltd. (NASDAQ:TSEM), Xoom (NASDAQ:XOOM)

Pfizer Inc. (NYSE:PFE) is planning to join hands with genetics testing company 23andMe to explore the role of genetics in a patient’s likelihood of contracting inflammatory bowel diseases (IBDs) such as Crohn’s disease and ulcerative colitis. Pfizer Inc. (NYSE:PFE) belongs to Healthcare sector. Its net profit margin is 59.30% and weekly performance is 2.46%. On last trading day company shares ended up $28.73. Pfizer Inc. … Continue reading Trader’s Recap : Pfizer (NYSE:PFE), SandRidge Energy (NYSE:SD), Pennsylvania Real Estate Investment Trust (NYSE:PEI), Tower Semiconductor Ltd. (NASDAQ:TSEM), Xoom (NASDAQ:XOOM)

Colin Pettis
Finance

Fast Moving Stocks : Merck (NYSE:MRK), Pfizer (NYSE:PFE), EVV, CEVA Inc. (NASDAQ:CEVA), Mesabi (NYSE:MSB)

Merck & Co. Inc. (NYSE:MRK) has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep. Merck & Co. Inc. (NYSE:MRK) belongs to Healthcare sector. Its net profit margin is 12.90% and weekly performance is 5.64%. On last trading day company shares ended up $58.78. Merck & Co. Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) … Continue reading Fast Moving Stocks : Merck (NYSE:MRK), Pfizer (NYSE:PFE), EVV, CEVA Inc. (NASDAQ:CEVA), Mesabi (NYSE:MSB)

Colin Pettis
Finance

Momentum Stocks: Amazon.com (NASDAQ:AMZN), Pfizer Inc. (NYSE:PFE), Sykes Enterprises (NASDAQ:SYKE), Fluor (NYSE:FLR), Cellular Dynamics International (NASDAQ:ICEL)

Amazon.com Inc. (NASDAQ:AMZN) and Hachette Book Group are entering the fourth month of a standoff over a new e-book contract. If another publisher’s experience is any guide, the dispute could drag on. Kensington Publishing Corp., a small New York book publisher, said it recently struck a new deal for physical and digital books with Amazon. Amazon.com Inc. (NASDAQ:AMZN) belongs to Services sector. Its net profit … Continue reading Momentum Stocks: Amazon.com (NASDAQ:AMZN), Pfizer Inc. (NYSE:PFE), Sykes Enterprises (NASDAQ:SYKE), Fluor (NYSE:FLR), Cellular Dynamics International (NASDAQ:ICEL)

Ryan Holtz
Finance

Healthcare ACtive Stocks: MannKind (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Bristol-Myers Squibb Co (NYSE:BMY)

MannKind Corporation (NASDAQ: MNKD) is a small company based in Valencia, California, poised to launch its FDA approved drug, Afrezza, as treatment indications for both Type 1 and Type 2 diabetes. Despite near unanimous backing from experts at the Advisory Committee (ADCOM) and the medical community, Mr. Market is still pessimistic on the company.  MannKind Corporation (NASDAQ:MNKD) stock performance was -2.50% in last session and finished the … Continue reading Healthcare ACtive Stocks: MannKind (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Bristol-Myers Squibb Co (NYSE:BMY)

Jason Knox
Finance

Best Stocks – Pfizer Inc. (NYSE:PFE) , Glu Mobile (NASDAQ:GLUU) , Central Garden & Pet Co (NASDAQ:CENT) , Cray (NASDAQ:CRAY) , Amedica (NASDAQ:AMDA)

Pfizer Inc. (NYSE:PFE) has so far failed in its $120 billion quest to buy its British rival AstraZeneca PLC. At least one analyst says the pressure is on for the pharmaceutical giant to get a big deal done and done quickly. Pfizer Inc. (NYSE:PFE) stock performance was -0.16% in last session and finished the day at $30.34. Traded volume was 14.84million shares in the last session … Continue reading Best Stocks – Pfizer Inc. (NYSE:PFE) , Glu Mobile (NASDAQ:GLUU) , Central Garden & Pet Co (NASDAQ:CENT) , Cray (NASDAQ:CRAY) , Amedica (NASDAQ:AMDA)

Kristen Barton